Patent · US Active

Universal sanger sequencing from next-gen sequencing amplicons

US10138519B2 · kind B2 · utility

0Cited by

0References

18Claims

0Family size

Assignee

Quest Diagnostics Investments LLC · US

Inventors

Heather R. Sanders · Olivehurst, US
Hai-Rong Li · Mission Viejo, US
Feras Hantash · San Juan Capistrano, US
Frederic Waldman · San Francisco, US

Key dates

Filing date	Dec 27, 2013
Grant date	Nov 27, 2018
Priority date	—
Expiry date	Dec 28, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/16
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Described herein are methods, compositions and kits directed to amplification of nucleic acids suitable for both next generation sequencing (NGS) and a second round of sequencing as validation, such as Sanger sequencing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.